To identify putative recurrent founder mutations and to study the role of RAD51B in female and male breast cancer predisposition and especially in familial breast cancer, we comprehensively screened the RAD51B gene in 172 Finnish cancer patients. This evidence concerns the gene RAD51B and breast carcinoma.